Home LiteratureArticle Details
PMID: 2405400 Published · ppublish English Journal Article

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H

Abstract

The role of tumor necrosis factor alpha (TNF-alpha) in the pathogenesis of autoimmune diabetes mellitus was tested in the nonobese mouse (NOD) model system. The effects of TNF-alpha were assessed on three levels: (i) insulitis development, (ii) development of overt diabetes, (iii) adoptive transfer of diabetes by splenic lymphocytes. Spontaneous diabetes mellitus was blocked in NOD mice by long-term treatment with recombinant TNF-alpha. Treatment with TNF-alpha caused a significant reduction in the lymphocytic infiltration associated with the destruction of the insulin-producing beta cells. Class II major histocompatibility complex Ia expression by islet cells was not up-regulated by TNF-alpha. Moreover, TNF-alpha was able to suppress the induction of diabetes in adoptive transfer of lymphocytes from diabetic female mice to young nondiabetic male NOD mice. These activities of TNF-alpha were shared by interleukin 1 alpha in this system. These studies have implications for the pathogenesis and therapy of autoimmune diabetes mellitus.

MeSH Terms
Animals Autoimmune Diseases/pathology,prevention & control Diabetes Mellitus, Experimental/immunology,pathology,prevention & control Female Immunization, Passive Interleukin-1/therapeutic use Islets of Langerhans/pathology Lymphocytes/immunology Male Mice Mice, Inbred BALB C Mice, Mutant Strains Recombinant Proteins/therapeutic use Tumor Necrosis Factor-alpha/therapeutic use
Chemicals
Interleukin-1 Recombinant Proteins Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Jacob C O
Department of Microbiology and Immunology, Stanford University School of Medicine, CA 94305.
Aiso S
Michie S A
McDevitt H O
Acha-Orbea H
References (30)
30 references, click to expand
  1. In vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone.
    J Immunol. 1988 Sep 1;141(5):1456-63 PMID: 3261749
  2. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
    J Immunol. 1988 Jun 1;140(11):3801-7 PMID: 2897395
  3. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.
    Science. 1988 Apr 29;240(4852):659-62 PMID: 2966437
  4. Class-II and IL2 receptor positive cells in the pancreas of NOD mice.
    Diabetologia. 1987 Nov;30(11):902-5 PMID: 3128459
  5. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.
    Nature. 1988 Jan 28;331(6154):356-8 PMID: 2893286
  6. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    J Immunol. 1988 Jan 1;140(1):108-11 PMID: 2447166
  7. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    J Immunol. 1987 Dec 15;139(12):4077-82 PMID: 3320203
  8. Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages.
    J Leukoc Biol. 1987 Dec;42(6):704-7 PMID: 3316463
  9. Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells.
    J Immunol. 1987 Sep 15;139(6):1935-8 PMID: 2442261
  10. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity.
    Acta Pathol Microbiol Immunol Scand C. 1987 Apr;95(2):55-63 PMID: 3300162
  11. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.
    Nature. 1987 Mar 19-25;326(6110):304-6 PMID: 3102976
  12. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.
    Jikken Dobutsu. 1986 Oct;35(4):501-4 PMID: 3492379
  13. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta.
    J Immunol. 1986 Dec 1;137(11):3644-8 PMID: 3491144
  14. Serum-free in vitro bioassay for the detection of tumor necrosis factor.
    J Immunol Methods. 1986 Nov 6;93(2):201-6 PMID: 3772113
  15. Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line.
    J Immunol. 1986 Nov 1;137(9):2853-6 PMID: 3093585
  16. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
    Diabetes. 1986 Aug;35(8):855-60 PMID: 3525284
  17. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.
    Science. 1986 Jun 20;232(4757):1545-7 PMID: 3086977
  18. Preventive effects of cyclosporin on diabetes in NOD mice.
    Diabetologia. 1986 Apr;29(4):244-7 PMID: 3519340
  19. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.
    Biochem Biophys Res Commun. 1986 Apr 14;136(1):94-101 PMID: 3486658
  20. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.
    Proc Natl Acad Sci U S A. 1986 Jan;83(2):446-50 PMID: 3455781
  21. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1985 Sep;82(18):6060-4 PMID: 3898078
  22. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.
    N Engl J Med. 1985 Aug 8;313(6):353-60 PMID: 3159965
  23. Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction.
    Diabetologia. 1984 Jul;27 Suppl:113-5 PMID: 6383913
  24. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.
    J Immunol. 1978 May;120(5):1497-503 PMID: 149171
  25. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.
    J Histochem Cytochem. 1970 May;18(5):315-33 PMID: 4192899
  26. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.
    Nucleic Acids Res. 1984 Feb 10;12(3):1687-96 PMID: 6322116
  27. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9719-23 PMID: 3264405
  28. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases.
    Autoimmunity. 1989;2(2):177-89 PMID: 2491601
  29. Breeding of a non-obese, diabetic strain of mice.
    Jikken Dobutsu. 1980 Jan;29(1):1-13 PMID: 6995140
  30. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.
    Lancet. 1983 Nov 12;2(8359):1115-9 PMID: 6138647
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1990-02-00
Pages
968-72
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC53391
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com